Making Dramatic Moves: Texas Instruments Inc. (NASDAQ:TXN), Exxon Mobil Corporation (NYSE:XOM), Knowles Corporation (NYSE:KN), Ruthigen, Inc. (NASDAQ:RTGN)

Texas Instruments Incorporated (NASDAQ:TXN) announced on 8th October that it has released new products to increase its bouquet of offerings under the analog-to-digital converter (ADC) portfolio. The new devices are being positioned to cater to the growing demand for ADC Devices in the high voltage category. The two new solutions released are the “eight-channel ADS8688 and four-channel ADS8684”. These devices process voltages in the range of + or – ve 10.24 volts. Texas Instruments Inc. (NASDAQ:TXN) in last trading activity moved down -7.13% to close at $42.74. Company weekly performance is -8.71% while its quarterly performance stands at -12.63%. Texas Instruments Inc. (NASDAQ:TXN) is -13.71% away from its 52 week high.Oil companies including Exxon Mobil (NYSE:XOM) could spend another $4 bil plugging leaks in the Kashagan oil pipeline in Kazakhstan. The petroleum giant, along with Royal Dutch Shell (NYSE:RDSA), France's Total and others have spent $50 bil on the pipeline, which started leaking and was closed weeks after completion. On last trading day Exxon Mobil Corporation (NYSE:XOM) moved down -0.24% to close at $91.60. Its volatility for the week is 1.74% while volatility for the month is 1.47%. XOM's sales growth for past 5 years was -1.70% and its EPS growth for past 5 years was -3.20%. Exxon Mobil Corporation (NYSE:XOM) monthly performance is -5.60%.Knowles Corp (NYSE:KN) was downgraded by Stephens from an “overweight” rating to an “equal weight” rating in a research note issued on Friday. On last trading day Knowles Corporation (NYSE:KN) moved down -7.23% to close at $22.46. Its volatility for the week is 9.62% while volatility for the month is 5.25%. KN's EPS growth for past 5 years was 0.00%. Knowles Corporation (NYSE:KN) monthly performance is -26.55%.Ruthigen Inc (NASDAQ:RTGN) announces the start of a Phase ½ clinical trial to gauge the tolerability, safety and potential efficacy of its lead drug RUT58-60. It will be used in abdominal surgery for assisting systemic antibiotics. Ruthigen has involved principal investigators at four clinical trial sites in U.S.: Helen Keller Hospital in Sheffield,AL, Medical center for the University of Virginia, Medical center for the University of South Alabama and Memorial Hermann Memorial City Medical center in Hoston. Ruthigen, Inc. (NASDAQ:RTGN) has 6.60% insider ownership while its institutional ownership stands at 2.00%. In last trading activity company's stock closed at $4.46.Ford Motor Company (NYSE:F) will release its preliminary third quarter 2014 financial results at 7 a.m. EDT Friday, Oct. 24. The following briefings will be conducted after the announcement: At 9 a.m. EDT, Mark Fields, Ford president and chief executive officer, and Bob Shanks, Ford executive vice president and chief financial officer, will host a conference call to discuss Ford's 2014 third quarter results. Ford Motor Company (NYSE:F) in last trading activity fell -0.36% to close at $13.79. Company weekly performance is -5.48% while its quarterly performance stands at -21.42%. Ford Motor Company (NYSE:F) is -23.90% away from its 52 week high.